v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI, Equity Method Investment, Including Noncontrolling Interest [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2023 $ 38 $ 162,960,438 $ (177,060,285)   $ (14,099,809)
Balance, shares at Dec. 31, 2023 384,223          
Net loss to common stockholders (2,160,154)   (2,160,154)
Noncontrolling interest            
Stock-based compensation 102,533   102,533
Stock-based compensation, shares   (34)          
Common Stock issued under Corporate Development and Advisory Agreement $ 2 152,998   153,000
Common Stock issued under Corporate Development and Advisory Agreement, shares   22,613          
Deemed dividends from trigger of down round provisions and extension of Assumed Warrants 656,164   656,164
Common Stock issued to KR8 under License Agreement $ 7 378,033   378,040
Common Stock issued to KR8 under License Agreement, shares   65,327          
Common Stock issued to MSK under Shares for Services Agreement $ 3 48   51
Common Stock issued to MSK under Shares for Services Agreement, shares   25,680          
Common Stock Issued to employee 15,694   15,694
Common stock issued to employee, shares   2,674          
Warrants issued for finder’s fee 17,147   17,147
Balance at Mar. 31, 2024 $ 50 164,283,055 (179,220,439)   (14,937,334)
Balance, shares at Mar. 31, 2024 500,483          
Balance at Dec. 31, 2024 $ 3 $ 119 195,864,697 (190,541,067) $ 5,323,752 (51,941) 5,271,811
Balance, shares at Dec. 31, 2024 26,972 1,183,942          
Net loss to common stockholders (788,583) (788,583) (788,583)
Noncontrolling interest (4,350) (4,350)
Stock-based compensation 27,716 27,716 27,716
Stock-based compensation, shares            
Common stock issued for conversions of Series A Preferred Stock $ 7 (7)
Common stock issued for conversions of Series A Preferred Stock, shares (308) 73,374          
Issuances of Series B Preferred Stock in exchange for Senior PIK Notes, net of finder’s fees 3,282,500 3,282,500 3,282,500
Issuances of Series B Preferred Stock in exchange for Senior PIK Notes, net of finder's fees, shares 3,457            
Issuance of Series C Preferred Stock for cash investment, net of finder’s fees 44,825 44,825 44,825
Issuance of Series C Preferred Stock for cash investment, net of finder's fees, shares 60            
Exchanges of Series B Preferred Stock for Series C Preferred Stock
Exchanges of Series B Preferred Stock for Series C Preferred Stock, shares 75            
Common stock issued for conversions and exchanges of notes payable $ 22 828,452 828,474 828,474
Common stock issued for conversions and exchanges of notes payable, shares   217,302          
Common stock issued under terms of notes payable $ 3 38,247 38,250 38,250
Common stock issued under terms of notes payable, shares   30,752          
Common stock issuable under terms of notes payable 68,225 68,225 68,225
Common stock issued and issuable for finder’s fees $ 1 141,189 141,190 141,190
Common stock issued and issuable for finder's fees, shares   11,494          
Common Stock issued under Corporate Development and Advisory Agreement $ 4 (4)
Common Stock issued under Corporate Development and Advisory Agreement, shares   39,389          
Common stock issued for legal settlement $ 17 570,646 570,663 570,663
Common stock issued for legal settlement, shares   165,077          
Deemed dividends from trigger of down round provisions and extension of Assumed Warrants 172,125 172,125 172,125
Balance at Mar. 31, 2025 $ 3 $ 173 $ 201,038,611 $ (191,329,650) $ 9,709,137 $ (56,291) $ 9,652,846
Balance, shares at Mar. 31, 2025 30,256 1,720,330